Jubilant Pharmova Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.3%1-day move

₹1007.80

prior close

₹1009.75

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.4+0.0+0.2+1.3+0.3-1.0-0.8-1.8-1.5-4.3-4.2+1.7—

Up moveDown movePending

AI summary

Jubilant Pharmova has informed exchanges about a scheduled management interaction with institutional investors on May 25, 2026. The meeting will be held in-person and is a group meeting with Dalton Investments and Marval Capital. The company plans to discuss the Q4'FY26 earnings presentation, which is scheduled to be filed on May 22, 2026 after the disclosure of quarterly financial results. The company has noted that the schedule may change due to exigencies on either side.

Likely market impact

This is a routine regulatory disclosure under SEBI listing obligations, indicating normal investor engagement activity. The post-results meeting timing (3 days after results filing) suggests standard post-earnings investor interaction ahead of the Q4'FY26 results release cycle.